Each week, we feature a physician executive. This week, our featured physician executive is Joseph M. Feczko, MD. Here's some informat...

Each Friday, we feature a physician executive. This week's featured physician executive is Freda C. Lewis-Hall, M.D., FAPA. Here...

Pfizer Global Manufacturing Announces Plans To Reconfigure Its Global Plant Network - - - Eight Sites Targeted for Exit; Reductions Recommen...

Who can keep up with the world of pharma/biotech? Pfizer had some major lay offs in the area of Research and Development (R&D). Accordin...

John LaMattina, PhD, was the former Pfizer president of global R&D (Research and Development). He has now joined the Boston-based ventur...

As Pfizer and Wyeth prepare for their merger, six out of the 20 combined research facilities will get closed. You can expect to see a heavy ...

We've started seeing more articles related to the topic of Twitter and the corporate world of Pharma/Biotech. Pharmavoice recently publi...

Would you like to meet some Chief Scientific Officers (CSOs)? What exactly does a CSO do? They keyword here is "strategy." Are you...

So much is changing in the healthcare industry. Have you spoken with your stock broker? If you're like me, then you probably try to do e...

Pfizer announced the appointment of Martine J. George, M.D., M.Sc, to Vice President of Medical Affairs for its Oncology Business Unit. Dr....

Pfizer was developing axitinib (a tyrosine kinase inhibitor or TKI) for the treatment of pancreatic cancer. Unfortunately, recent Phase III ...

Rumors are circulating... it's still way too early to say, but it sure is an interesting headline. Maybe it won't be for $60 billion...

Pfizer has released a new website focusing on medication safety. www.Pfizer.com/medicinesafety This site addresses some important issues reg...